Literature DB >> 6416511

Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production.

N P Mann, D I Johnston, W G Reeves, M A Murphy.   

Abstract

Semisynthetic human insulin and highly purified porcine insulin were compared in a double blind crossover study in 21 diabetic children. Glycosylated haemoglobin values at the end of four month treatment periods were higher after treatment with human insulin than after treatment with porcine insulin (mean 15.7% (SD 2.3%) v 14.2% (2.3%); p less than 0.01). Higher fasting blood glucose concentrations occurred during treatment with human insulin than with porcine insulin (mean 12.0 (SD 2.1) v 11.0 (2.4) mmol/1; mean 216 (SD 38) v 198 (43) mg/100 ml; p less than 0.05), but there were no significant differences at other time points during the day. The incidence of hypoglycaemia was similar for both treatment groups. Concentrations of antibody reactive with porcine and human insulins were similar for the two treatment groups, although greater fluctuation was observed in the amount of antibody reactive with human insulin. Semisynthetic human insulin is safe and effective in diabetic children, although further work is needed to devise regimens which achieve optimal blood glucose control.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416511      PMCID: PMC1549785          DOI: 10.1136/bmj.287.6405.1580

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  Childhood diabetes. Its course, and influence on the second and third generations.

Authors:  P WHITE
Journal:  Diabetes       Date:  1960 Sep-Oct       Impact factor: 9.461

2.  An immunochemical method for the quantitation of insulin antibodies.

Authors:  W G Reeves; U Kelly
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

3.  Insulin antibodies in the serum of diabetic children treated from the diagnosis of the disease with highly purified insulins.

Authors:  H K Akerblom; A L Mäkelä
Journal:  Acta Paediatr Scand Suppl       Date:  1977

4.  Total glycosylated haemoglobin (HbA1) levels in diabetic children.

Authors:  N P Mann; D I Johnston
Journal:  Arch Dis Child       Date:  1982-06       Impact factor: 3.791

5.  Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients.

Authors:  A J Clark; R O Adeniyi-Jones; G Knight; J M Leiper; P G Wiles; R H Jones; H Keen; A C MacCuish; J D Ward; P J Watkins; J M Cauldwell; A Glynne; J B Scotton
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

6.  Insulin antibodies, insulin dose, and diabetic control.

Authors:  S Walford
Journal:  Lancet       Date:  1983-02-19       Impact factor: 79.321

7.  Human insulin: facile synthesis by modification of porcine insulin.

Authors:  M A Ruttenberg
Journal:  Science       Date:  1972-08-18       Impact factor: 47.728

8.  Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system.

Authors:  M Klier; W Kerner; A A Torres; E F Pfeiffer
Journal:  Diabetes Care       Date:  1981 Mar-Apr       Impact factor: 19.112

9.  Characterization of seven C-peptide antisera.

Authors:  O K Faber; C Binder; J Markussen; L G Heding; V K Naithani; H Kuzuya; P Blix; D L Horwitz; A H Rubenstein
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

10.  The effect of insulin antibodies on insulin dose and diabetic control.

Authors:  S Walford; S P Allison; W G Reeves
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

View more
  13 in total

1.  Human insulin and unawareness of hypoglycaemia: need for a large randomised trial.

Authors:  M Egger; G D Smith; A Teuscher
Journal:  BMJ       Date:  1992-08-08

2.  Human insulin.

Authors:  J Pickup
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

3.  Human insulin.

Authors:  P Home
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

Review 4.  Human insulin.

Authors:  J Pickup
Journal:  BMJ       Date:  1989-10-21

5.  Evaluation of impact on diabetic control of increased surveillance, and of human and U-100 insulins.

Authors:  M McKenna; M Dolan; T Loughlin; H Clarke; R M Conroy; A Heffernan; T J McKenna
Journal:  Ir J Med Sci       Date:  1987-12       Impact factor: 1.568

Review 6.  Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 7.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

8.  Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin.

Authors:  A S Luyckx; J C Daubresse; C Jaminet; A Scheen; P J Lefebvre
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

Review 9.  Insulin-dependent (type I) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

10.  Metabolic rhythms in adolescents with diabetes during treatment with porcine or human insulin.

Authors:  M D Hocking; J Crase; P H Rayner; M Nattrass
Journal:  Arch Dis Child       Date:  1986-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.